Brief: Herantis Pharma starts Phase II study with Cis-UCA Eye Drops

Herantis Pharma Oyj

07/01/2015 07:01

Jan 7 (Reuters) - Herantis Pharma Oyj  HRTIS.HE : 
    * Initiates Phase II study with Cis-UCA Eye Drops in 
patients with Dry Eye Syndrome 
    * Study results expected in Q3 2015 
    * Aims to publish top-line data of Phase II study by Sept. 
2015 
    * Previously estimated that top-line results would be 
announced by end of 2015 
 
Source text for Eikon:  ID:nHUG72Pf2X  
Further company coverage:  HRTIS.HE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;)) 
 
Keywords: HERANTIS PHARMA/BRIEF